Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Thomas Sciascia > Profile

Thomas Sciascia

Affiliations

  • Chief Scientific Officer at Trevi Therapeutics Inc. (TRVI), 2025-06-03
  • Svp Clin Dev & Reg Aff & Cmo at Penwest Pharmaceuticals Co (PPCO), 2010-11-08
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TRVI $6.60 2,631 $17,364.60 221,373 2025-03-25 Filing
TRVI $2.96 16,496 $48,882.60 220,315 2024-08-19 Filing
TRVI $2.76 18,660 $51,440.02 220,315 2024-08-16 Filing
TRVI $2.79 12,745 $35,512.67 220,315 2024-08-15 Filing
TRVI $2.75 100 $275.00 220,315 2024-08-14 Filing